HB 1431 -  International Drug Reference Pricing

General Bill by Fine and Massullo
International Drug Reference Pricing: Requires prescription drug manufacturer permitholders to annually report certain international price data to AHCA; provides for administrative enforcement via specified fine & permit suspension; requires AHCA to contract with entity to designate reference price source countries & establish reference prices for prescription drugs based on certain criteria; requires agency contractor to weigh reference price benchmark value of such countries in two or more tiers, using specified criteria; requires agency contractor to analyze specified data to compare prices among source countries using specified exchange rate source; requires agency contractor to establish reference price for prescribed drugs or products; requires agency contractor to provide reference prices by specified date each year; requires AHCA to publish prices online within specified time; requires pharmacies to charge no more than reference price for cash-paying patients; requires certain health insurers to provide reimbursement for certain prescription drugs no higher than reference price; requires health insurers to use certain savings to offset certain payer costs; requires each health insurer to document anticipated savings & premium reductions in rate filings following availability of reference prices; requires each health insurer to assess actuarial effect of reference pricing program for each insurer product for each plan year; requires each health insurer to submit annual report on assessed effect of such program to OIR or AHCA; requires OIR & AHCA to submit joint report to Governor & Legislature; requires every health maintenance organization to comply with provisions of specified section.
Effective Date: July 1, 2024
Last Event: Died in Appropriations Committee on Friday, March 8, 2024 2:25 PM

Referred Committees and Committee Actions

House Referrals

Related Bills

Bill # Subject Relationship
Bill #: SB 1750 Subject: International Drug Reference Pricing Relationship: Similar

Bill Text

Staff Analysis

Chamber Committee
Chamber: House Committee: Select Committee on Health Innovation 1/23/2024 4:10:17 PM
Chamber: House Committee: Select Committee on Health Innovation 1/21/2024 5:39:48 PM

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: H Died in Appropriations Committee Time: 03/08/2024 - 2:25 PM Member: Committee: Appropriations Committee Version: __
Event: H Now in Appropriations Committee Time: 01/23/2024 - 4:31 PM Member: Committee: Appropriations Committee Version: __
Event: H Reported out of Select Committee on Health Innovation Time: 01/23/2024 - 4:31 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Favorable by Select Committee on Health Innovation Time: 01/22/2024 - 7:08 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Added to Select Committee on Health Innovation agenda Time: 01/18/2024 - 4:08 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Now in Select Committee on Health Innovation Time: 01/13/2024 - 9:36 AM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Referred to Health & Human Services Committee Time: 01/13/2024 - 9:36 AM Member: Committee: Health & Human Services Committee Version: __
Event: H Referred to Appropriations Committee Time: 01/13/2024 - 9:36 AM Member: Committee: Appropriations Committee Version: __
Event: H Referred to Select Committee on Health Innovation Time: 01/13/2024 - 9:36 AM Member: Committee: Select Committee on Health Innovation Version: __
Event: H 1st Reading Time: 01/09/2024 - 11:31 PM Member: Committee: Version: __
Event: H Filed Time: 01/06/2024 - 5:46 PM Member: Fine Committee: Version: __

Statutes Referenced by this Bill

Statute Other Bill Citations
465.0244 SB 1750
499.044 SB 1750
627.6044 SB 1750
641.30 SB 1750